Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection
Clinical trial NCT04801836 · UNKNOWN
Trial details
- NCT number
- NCT04801836
- Sponsor
- NEURALIS s.a.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2022-03-04
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.